• MMP7 Drives EMT and Liver Fibrosis via E-cadherin/β-catenin

  2026-05-28

  This study establishes matrix metalloproteinase 7 (MMP7) as a key mediator of epithelial–mesenchymal transition (EMT) and liver fibrosis in biliary atresia (BA) through cleavage of E-cadherin and activation of β-catenin signaling. The findings highlight MMP7 as a promising therapeutic target and provide mechanistic insight into rapid fibrotic progression in BA.

• Enhancing Pancreatic Cancer Cell Death via Caspase-8/c-FLIPL

  2026-05-28

  A recent study demonstrates that pharmacological targeting of the caspase-8/c-FLIPL heterodimer, combined with MCL1 inhibition, enhances apoptotic cell death in pancreatic cancer cells by promoting complex II assembly. This combinatorial approach offers mechanistic insight into overcoming apoptosis resistance in cancer and informs experimental strategies for researchers investigating cell death pathways.

• Adap2 Drives Cardiomyocyte Hypertrophy via Surface β1-Integr

  2026-05-27

  This study elucidates the previously uncharacterized role of Adap2 (ArfGAP with dual pleckstrin homology domains 2) in promoting hypertrophy of cultured neonatal cardiomyocytes. Through adenoviral-mediated overexpression and membrane protein analysis, the research demonstrates that Adap2 enhances cell surface β1-integrin accumulation and cell size, highlighting a distinct molecular mechanism from its homolog Adap1.

• N4-Acetylcytidine in RNA Metabolism: Mechanisms and Assay St

  2026-05-27

  Explore how N4-Acetylcytidine advances RNA epigenetics research with new structural insights into nucleotide processing. This in-depth article reveals unique mechanistic findings and assay considerations for acetylated cytidine, setting it apart from standard workflows.

• SAR131675: Selective VEGFR-3 Inhibitor for Lymphangiogenesis

  2026-05-26

  SAR131675 is a potent and selective VEGFR-3 inhibitor, acting as an ATP-competitive compound with nanomolar efficacy. It demonstrates high specificity for VEGFR-3, robust anti-lymphangiogenic and anti-angiogenic activity, and is a validated tool for dissecting VEGFC-driven pathways in fibrosis and tumor models.

• Bifendate Blocks Autophagy and Reduces Oleic Acid-Induced Li

  2026-05-26

  The reference study demonstrates that bifendate inhibits autophagy at multiple steps, including autophagosome-lysosome fusion and lysosomal reformation, and significantly attenuates oleic acid-induced lipid droplet accumulation in vitro. This work advances our understanding of bifendate’s cellular mechanisms and suggests potential translational relevance for hepatic lipid storage disorders.

• Vitamin C (CAS 50-81-7): Advanced Protocols for Tumor and An

  2026-05-25

  Explore the nuanced anticancer and antiviral roles of Vitamin C (ascorbic acid) in translational research. This article offers a protocol-focused perspective and practical assay guidance distinct from prior reviews.

• N1-Methyl-Pseudouridine-5'-Triphosphate in RNA Stability Wor

  2026-05-25

  N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) is transforming in vitro transcription and mRNA vaccine development by dramatically enhancing RNA stability and translation fidelity. This article details advanced workflows, troubleshooting strategies, and practical protocol improvements for leveraging APExBIO’s high-purity N1-Methylpseudo-UTP in next-generation RNA research.

• Dibutyryl-cAMP, Sodium Salt: Applied Workflows in cAMP Signa

  2026-05-24

  Dibutyryl-cAMP, sodium salt (DBcAMP sodium salt) enables precise, reproducible activation of cAMP-dependent pathways across diverse experimental models. This guide uniquely synthesizes advanced workflow design, troubleshooting, and novel insights from recent neuroinflammation research to maximize your assay outcomes.

• Salinomycin (SKU A3785): Precision Tool for Hepatocellular C

  2026-05-23

  This article delivers an evidence-based guide for leveraging Salinomycin (SKU A3785) as a polyether ionophore antibiotic in hepatocellular carcinoma research. Through scenario-driven Q&A, it addresses practical challenges in cell viability assays, protocol optimization, and product selection, providing actionable solutions grounded in peer-reviewed literature and robust product specifications.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Fluorescent Assay Pr

  2026-05-22

  The Cy5 Goat Anti-Mouse IgG (H+L) Antibody enables high-sensitivity fluorescent detection of mouse immunoglobulins in immunoassays. This Cy5-conjugated secondary antibody, supplied by APExBIO, delivers robust signal amplification and reproducibility in immunohistochemistry and immunocytochemistry workflows.

• Dorsomorphin (Compound C): AMPK and BMP Pathway Inhibition F

  2026-05-22

  Dorsomorphin (Compound C) is a reversible, ATP-competitive AMPK inhibitor with high selectivity and dual functionality in BMP signaling inhibition. This article details its biochemical action, verified applications in autophagy and iron metabolism modulation, and evidence-driven protocol guidance for laboratory use.

• SR 11302: Redefining AP-1 Blockade in Translational Cancer R

  2026-05-21

  Explore how SR 11302, a selective AP-1 transcription factor inhibitor, empowers translational oncology by advancing mechanistic understanding, experimental rigor, and clinical strategy. This article synthesizes recent literature, including evidence on immune modulation and tumor microenvironment, and offers actionable guidance for researchers aiming to harness AP-1 blockade for chemoprevention and therapeutic innovation. Distinct from standard product pages, this thought-leadership piece connects molecular insight with protocol expertise and translational foresight.

• Single-nucleus Profiling Reveals ATRNL1's Role in Atrial Fib

  2026-05-21

  This study employed large-scale single-nucleus RNA sequencing to map cell-type-specific transcriptional changes in atrial fibrillation (AF), revealing ATRNL1 as a key gene upregulated in cardiomyocytes. The findings highlight ATRNL1's involvement in cardiac stress response and conduction, offering new directions for personalized AF therapies.

• LGK-974: High-Precision PORCN Inhibitor for Wnt Pathway Rese

  2026-05-20

  LGK-974 stands out as a potent and highly specific PORCN inhibitor, enabling robust dissection of the Wnt signaling pathway in both developmental biology and cancer models. Its nanomolar potency, low cytotoxicity, and proven efficacy in Wnt-driven tumor regression make it the tool of choice for translational and mechanistic studies.

8538 records 17/570 page Previous Next First page 上5页 1617181920 下5页 Last page